Alendronate in bone cement: Fatigue life degraded by liquid, not by powder

Clinical Orthopaedics and Related Research

Volumn 445, Issue , 2006, Pages 233-238

  Lewis, Gladius ^a   Janna, Si ^a  

^a University of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE CEMENT;

ARTICLE; DRUG FORMULATION; DRUG MIXTURE; JOINT PROSTHESIS; PRIORITY JOURNAL; PROSTHESIS MATERIAL; WEIGHT BEARING; ARTHROPLASTY; BIOMECHANICS; MATERIALS TESTING; PARTICLE SIZE; POWDER; PROSTHESIS FAILURE;

ALENDRONATE; ARTHROPLASTY, REPLACEMENT; BIOMECHANICS; BONE CEMENTS; MATERIALS TESTING; PARTICLE SIZE; POWDERS; PROSTHESIS FAILURE;

EID: 33646827667     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000201162.59819.28     Document Type: Article

References (30)

1. American Society for Testing and Materials (ASTM). Standard F 2118-01a. Test method for constant amplitude of force controlled fatigue testing of acrylic bone cement materials. 2002 Annual Book of ASTM Standards. Medical Devices and Emergency Medical Devices. Vol 13.01. West Conshohocken. PA: ASTM International. 2002:1673-1680.
2. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg. 2004;43:285-289.
3. Bhandari M, Bajammal S, Guyatt GH. Griffith L, Busse JW, Schunemann H, Einhorn TA. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. J Bone Joint Surg. 2005;87:293-301.
4. Cremers SC, Lodder MC, Den Hartigh J, Vermeij P, Van Pelt P, Lems WF, Papapoulos SE, Dijkmans BA. Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritis. J Rheumat. 2004;31:1732-1737.
5. Cristofolini L, Minari C, Viceconti M. A methodology and criterion for acrylic bone cement fatigue tests. Fatigue Fract Eng Mater Struct. 2001;23:953-957.
6. Cristofilini L, Minari C, Viceconti M. Reply to Letter to Editor. Fatigue Fract Eng Mater Struct. 2002;25:317-318.
7. Dunne NJ, Orr JF, Mushipe M, Eveleigh R. The relationship between porosity and fatigue characteristics of bone cements. Biomaterials. 2003;24:239-245.
8. Fleisch H. Bisphosphonates in osteoporosis. Eur Spine J. 2003;12(suppl):S142-S146.
9. Jasty M, Maloney WJ, Bragdon CR, O'Connor DO, Haire T, Harris WH. The initiation of failure in cemented femoral components of hip arthroplasties. J Bone Joint Surg. 1991;73:551-558.
10. Krause WR, Grimes LW, Mathis RS. Fatigue testing of acrylic bone cements: statistical concepts and proposed test methodologies. J Biomed Mater Res. 1988;2(suppl):179-190.
11. Kurtz SM, Villarraga ML, Zhao K, Edidin AA. Static and fatigue mechanical behavior of bone cement with elevated barium sulfate content for treatment of vertebral compression fractures. [Erratum in: Biomaterials. 2005;26:5926.] Biomaterials. 2005;26:3699-3712.
12. Lewis G. Properties of acrylic bone cement: state of the art review. J Biomed Mater Res. 1997;38:155-182.
13. Lewis G. Fatigue testing and performance of acrylic bone-cement materials: state-of-the-art review. J Biomed Mater Res B Appl Biomater. 2003;66:457-486.
14. Lewis G, Sadhasivini A. Estimation of the minimum number of test specimens for fatigue testing of acrylic bone cement. Biomaterials. 2004;25:4425-4432.
15. Maire E, Buffiere J-Y, Salvo L, Blandin JJ, Ludwig W, Letang JM. On the application of x-ray microtomography in the field of materials science. Adv Eng Mater. 2001;3:539-546.
16. Malchau H, Herberts P, Eisler T, Garellick G, Soderman P. The Swedish Total Hip Replacement Register. [Erratum in: J Bone Joint Surg Am. 2004;86:363.] J Bone Joint Surg. 2002;84(suppl 2):2-20.
17. Morris CD, Einhorn TA. Bisphosphonates in orthopaedic surgery. J Bone Joint Surg. 2005;87:1609-1618.
18. Murphy BP, Prendergast PJ. On the magnitude and variability of the fatigue strength of acrylic bone cement. Int J Fatigue. 2000;22:855-864.
19. Peter B, Pioletti DP, Laib S, Bujoli B, Pilet P, Janvier P, Guicheux J, Zambelli PY, Bouler JM, Gauthier O. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone. 2005;36:52-60.
20. Prendergast PJ. The functional performance of orthopaedic bone cement. Key Eng Mater. 2001;198-199:291-300.
21. Race A, Miller MA, Ayers DC, Mann KA. Early cement damage around a femoral stem is concentrated at the cement/bone interface. J Biomech. 2003;36:489-496.
22. Sabokbar A, Fujikawa Y, Murray DW, Athanasou NA. Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Ann Rheum Dis. 1998;57:614-618.
23. Shannon BD, Klassen JF, Rand JA, Berry DJ, Trousdale RT. Revision total knee arthroplasty with cemented components and uncemented intramedullary stems. J Arthroplasty. 2003;18(7 suppl 1):27-32.
24. Shigley JE, Mischke CR. Mechanical Engineering Design. Ed 6. New York, NY: McGraw-Hill; 2001:165-172.
25. Shimshi M, Abe E, Fisher EA, Zaidi M, Fallon JT. Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice. Biochem Biophys Res Commun. 2005;328:790-793.
26. Soltau J, Drevs J. The role of bisphosphonates in oncology. Drugs Future. 2004;29:911-921.
27. Toussirot E, Wendling D. Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies. Expert Opin Pharmacother. 2005;6:35-43.
28. Weibull W. A statistical distribution function of wide applicability. J Appl Mech. 1951;18:293-297.
29. Wilkinson JM, Eagleton AC, Stockley I, Peel NF, Hamer AJ, Eastell R. Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: a randomized trial. J Orthop Res. 2005; 23:1-8.
30. Zenios M, Nokes L, Galasko CS. Effect of a bisphosphonate, disodium pamidronate, on the quasi-static flexural properties of Palacos R acrylic bone cement. J Biomed Mater Res BAppl Biomater. 2004; 71:322-326.